MEDAREX LLC has a total of 83 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Norway, Republic of Korea and Japan. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are E R SQUIBB & SONS LLC, IMMUNEXT INC and ALDERBIO HOLDINGS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Norway | 11 | |
#2 | Republic of Korea | 9 | |
#3 | Japan | 8 | |
#4 | United States | 8 | |
#5 | Singapore | 7 | |
#6 | EAPO (Eurasian Patent Organization) | 6 | |
#7 | Taiwan | 6 | |
#8 | EPO (European Patent Office) | 5 | |
#9 | Australia | 4 | |
#10 | Hong Kong | 4 | |
#11 | Israel | 3 | |
#12 | Montenegro | 3 | |
#13 | New Zealand | 3 | |
#14 | Peru | 3 | |
#15 | Canada | 1 | |
#16 | Malaysia | 1 | |
#17 | Tunisia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology | |
#5 | Agriculture | |
#6 | Micro-structure and nano-technology | |
#7 | Optics |
# | Name | Total Patents |
---|---|---|
#1 | Cardarelli Josephine M | 22 |
#2 | Korman Alan J | 21 |
#3 | Huang Haichun | 20 |
#4 | Witte Alison | 15 |
#5 | Yamanaka Mark | 14 |
#6 | Zens Kyra D | 14 |
#7 | Thudium Kent B | 13 |
#8 | Selby Mark | 13 |
#9 | Gangwar Sanjeev | 12 |
#10 | Leblanc Heidi | 11 |
Publication | Filing date | Title |
---|---|---|
SG2014012298A | Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof | |
EP2185188A1 | Site-specific attachment of drugs or other agents to engineered antibodies with c-terminal extensions | |
MY152169A | Human anti-b7rp1 neutralizing antibodies | |
TW200833683A | Chemical linkers and cleavable substrates and conjugates thereof | |
EP1934261A2 | Human monoclonal antibodies to cd70 | |
AU2006214033A1 | Monoclonal antibodies against CD30 lacking fucosyl residues | |
KR20140033210A | Interferon alpha receptor 1 antibodies and their uses | |
ME00226B | Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |